Abstract
Weibel–Palade bodies (WPB) are elongated, rod-like secretory organelles unique to endothelial cells that store the pro-coagulant von-Willebrand factor (VWF) and undergo regulated exocytosis upon stimulation with Ca2+- or cAMP-raising agonists. We show here that WPB preferentially initiate fusion with the plasma membrane at their tips and identify synaptotagmin-like protein 2-a (Slp2-a) as a positive regulator of VWF secretion most likely mediating this topological selectivity. Following secretagogue stimulation, Slp2-a accumulates at one WPB tip before fusion occurs at this site. Depletion of Slp2-a reduces Ca2+-dependent secretion of highly multimeric VWF and interferes with the formation of actin rings at WPB–plasma membrane fusion sites that support the expulsion of the VWF multimers and most likely require a tip-end fusion topology. Phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P2] binding via the C2A domain of Slp2-a is required for accumulation of Slp2-a at the tip ends of fusing WPB, suggesting that Slp2-a mediates polar exocytosis by initiating contacts between WPB tips and plasma membrane PI(4,5)P2.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Weibel–Palade bodies (WPB) are specialized lysosome-related secretory organelles of endothelial cells. They store and secrete the pro-coagulant glycoprotein von-Willebrand factor (VWF), which is the defining cargo of WPB and whose highly multimeric tubular assembly determines the characteristic rod-like shape of WPB. Upon exocytosis, VWF unfolds into VWF strings that provide a scaffold for platelets to efficiently form a platelet plug inside injured blood vessels (for reviews, see [1,2,3,4]). P-selectin and CD63, which are transmembrane proteins of WPB [5, 6], are presented on the endothelial cell surface upon WPB exocytosis, and then support interactions between leukocytes and the vessel wall [7, 8]. Therefore, WPB exocytosis, which is triggered by secretagogues elevating intracellular Ca2+ or cAMP, rapidly transforms the normally anti-adhesive surface of blood vessels into an adhesive one capable of capturing leukocytes and platelets (for a review, see [9]). Hence, acute WPB exocytosis must be tightly controlled and activated only at times of injury to blood vessels, in inflammatory conditions, or upon other types of insult.
WPB form at the trans-Golgi network and undergo a maturation process that involves a tight packing of VWF tubules resulting in the rod-like morphology. Maturation is also accompanied by the recruitment of Rab GTPases including Rab3 isoforms and in particular Rab27a, a long-known marker for WPB [10,11,12,13,14,15]. These, in turn, recruit effector proteins, which regulate WPB dynamics and exocytosis. One Rab27a effector implicated in WPB maturation is Myosin VIIA And Rab Interacting Protein (MyRIP), also known as synaptotagmin-like protein lacking C2 domains-c (Slac2-c), which anchors WPB at the cortical actin cytoskeleton, thereby preventing the exocytosis of premature WPB [16,17,18]. Synaptotagmin-like protein 4-a (Slp4-a), an effector of Rab3 and Rab27 isoforms, promotes WPB exocytosis following secretagogue stimulation [10]. It functions by interacting with syntaxin-binding protein 1 (STXBP1), also known as Munc18-1, which in turn binds SNARE proteins including syntaxin 3 [19]. The involvement of SNARE complexes in WPB exocytosis is illustrated by the dependency of VWF secretion on N-ethylmaleimide-sensitive factor (NSF) [20,21,22]. Candidates for the catalytic SNARE complex mediating WPB exocytosis include, in addition to syntaxin 3, VAMP3, VAMP8, syntaxin 4, and SNAP23 [19, 21, 23,24,25]. Plasma membrane (PM) lipids, specifically phosphatidic acid (PA) and phosphatidylinositol(4,5)-bisphosphate (PI(4,5)P2), also play an important role in mediating the WPB fusion. Both accumulate at sites of WPB exocytosis and enzymes generating these lipids, phospholipase D1 (PLD1) and PI4P 5-kinase (PI4P5Kγ), positively support WPB exocytosis and VWF secretion [26, 27]
Different modes of WPB–PM fusion have been described. They include full fusions where the WPB membrane flattens completely into the PM and all cargo is released, and kiss-and-run fusion events that permit transient fusion pore opening and selective release of (smaller) WPB cargo. Other modes of WPB exocytosis are compound fusions where individual WPB fuse inside the cell to form a secretory pod that eventually fuses with the PM, cumulative/sequential fusions characterized by a second WPB fusing to a first that had already fused with the PM, and cavicapture-like events that are characterized by fusion pores allowing the release of large cargo like VWF but restricting the WPB membrane from fully collapsing into the PM [3, 28,29,30]. Interestingly, at least the latter events are accompanied by an actin ring or coat that forms at the base (PM-distal) of the fused WPB membrane and supports the release of the large VWF cargo through actomyosin contractility [31].
Given the unique, rod-like shape of WPB and previous cryo-EM studies that suggested a tip-end orientation of peripheral WPB [32], we addressed the question of whether WPB prefer a specific topology when fusing with the PM, i.e., whether they fuse randomly, or preferentially with either the tip or the lateral side pointing toward the membrane. We show that tip-end fusion is highly favored and consider this topology relevant as it could affect the release of small versus large WPB cargo and the assembly of actin rings at the base of fused WPB. In search of factors that confer such topical selectivity, we identify synaptotagmin-like protein 2-a (Slp2-a), a Rab27a effector that recently has been linked to WPB exocytosis [33]. Slp2-a serves as a positive regulator of the secretion of highly multimeric VWF and upon secretagogue stimulation becomes concentrated at the WPB tip which will undergo fusion. Slp2-a is known to bind phosphatidylserine (PS) and PI(4,5)P2 [34] and we show that PI(4,5)P2 binding is required for tip-end localization of Slp2-a at fusing WPB. The Slp2-a mediated tip-end fusion topology is important for an assembly of actin rings at the base of fused WPB that supports the expulsion of highly multimeric forms of VWF as both events are compromised in endothelial cells depleted of Slp2-a.
Results
Topology of WPB fusion
The fusion of a rod-shaped WPB with the plasma membrane (PM) can, in principle, proceed via two morphologically distinct events: the fusion pore could open either on the lateral organelle surface, or on one of the organelle’s approximately hemispherical tips (Fig. 1A). To quantify the relative numbers of lateral and tip WPB fusions in primary human umbilical vein endothelial cells (HUVEC), we performed time-lapse live-cell microscopy with simultaneous epifluorescence and TIRF illumination of VWF-EGFP marked WPB stimulated for exocytosis with histamine during acquisition. In these conditions, WPB often appear tethered at or very close to the PM even before fusion. In such cases, one of the tips of the WPB is visible in both the TIRF and epifluorescence channels, while the rest of the organelle is only visualized with epifluorescence illumination, indicating that it extends away from the evanescent TIRF illumination field and into the cell interior (Fig. 1B). Over time, the position of the WPB tip that is closest to the PM remains fixed, even when the “tail” of the organelle rotates around the “head” portion of the organelle within the TIRF field (Fig. 1B).
At an acquisition rate of 4 frames per second, we were able to identify two distinct categories of fusion events. Some fusion events were consistent with a lateral fusion mode as they presented an oblong fusion spot that essentially preserved the orientations of the long and short axes of the pre-fusion WPB (Fig. 1C, Video 1). These WPB were mostly located within the TIRF field across their entire length and thus oriented parallel to the coverslip. On the other hand, we observed fusion events where the bright fusion spot remained confined to a roundish area at the place where the WPB had been within the TIRF field before fusion, consistent with tip fusions (Fig. 1D, Video 2). In the latter case, the part of the organelle that was distal to the fusion pore often retained its elongated shape for a few seconds before collapsing into the fusion spot. Of note, we did not observe WPB that had round fusion spots in their middle with non-collapsed elongated parts of the WPB extending to either side still visible after fusion. We quantified the relative frequencies of types of fusion events and found that overall, less than 5% of WPB fusions are unambiguously lateral, whereas the other fusion events showed aspects of a round fusion spot (Fig. 1E). Together, these data show that WPB preferentially fuse with the PM in a “head on” orientation. They furthermore imply that one WPB tip often becomes tethered to a PM proximal site before fusion.
Slp2-a: an Rab27a effector localizing to the fusion-competent tip of WPB in stimulated HUVEC
Next, we searched for proteins that might confer fusogenic functionality to the WPB tip. As Rab27a is a protein specifically recruited to mature elongated WPB residing in the cell periphery [12], we concentrated on Rab27a effectors as candidates for mediating a tip-end fusion. We, therefore, assessed the presence of a panel of Rab27a effectors in HUVEC lysates by Western blot. We confirmed the expression of MyRIP and Slp4-a [10, 31], and furthermore identified the presence of Slp1, Slp2-a, and Noc2 at the protein level (Fig. 1F). Among these, Slp2-a is known to play a role in targeting secretory granules to the PM of pancreatic α cells [34] and gastric-surface mucous cells [35], affecting granule secretion in cytotoxic T lymphocytes (CTLs) [36, 37] and, as recently shown, regulating the exocytic activity of WPB [33]. In addition to binding Rab27a via its N-terminal SHD (Slp homology domain), Slp2-a also binds Ca2+ and interacts with PS and PI(4,5)P2 via its C-terminal C2 domains [34] and thus could potentially function as a Ca2+-regulated bridge between WPB and the PS/PI(4,5)P2-rich PM. Therefore, we first verified that Slp2-a associates with WPB in HUVEC by expressing Slp2-a fused to GFP together with VWF-RFP. Slp2a-wt-GFP clearly co-localized with the VWF-RFP signal on WPB (Fig. 2A). We did not observe any obvious changes in WPB number, localization, or morphology upon Slp2a-GFP expression. Next, we analyzed the subcellular localization of several Slp2-a truncation mutants (overview of the constructs used in Fig. 2). While the Slp2a-SHDonly-GFP and Slp2a-ΔC2AB-GFP mutants co-localized with WPB in a manner similar to the wild-type construct, Slp2a-ΔSHD-GFP and Slp2a-C2ABonly-GFP were found mainly on the PM and showed no WPB staining (Fig. 2B). These data confirm that the Rab27a interacting SHD is necessary for recruiting Slp2-a to WPB, while the C2 domains are recruited to the plasma membrane, mediated possibly by PI(4,5)P2 and/or PS binding of the Slp2-a C2A domain [33].
To further analyze the role of Rab27a in recruiting Slp2-a to WPB, we used point mutants within the SHD of Slp2-a known to disrupt either binding to Rab27, Rab3, and Rab8 (Slp2a-E11A/R32A) or selectively to Rab3 and Rab8 only (Slp2a-V18A) [38]. While Slp2a-E11A/R32A-GFP assumed cytosolic and plasma membrane localization, Slp2a-V18A-GFP localized to WPB, with some general plasma membrane/cytosolic distribution (Fig. 2C). Moreover, depletion of Rab27a in HUVEC resulted in a loss of WPB association of Slp2a-wt-GFP (Fig. S1). These data demonstrate that recruitment of Slp2a-GFP to WPB depends on Rab27a, but not on Rab8 or Rab3 isoforms.
To assess the dynamics of Slp2-a localization during WPB fusion, we performed time-lapse live-cell confocal microscopy of HUVEC transfected with Slp2a-GFP and VWF-RFP. In this setting, individual WPB–PM fusion events can be visualized by the collapse of the elongated VWF-RFP signal into a round fusion spot [29, 39]. Upon addition of histamine, Slp2a-GFP accumulated on most WPB in distinct puncta, with one Slp2a-GFP puncta per WPB that were usually located at one of the tips of the organelle (Fig. 3A, Video 3). We will refer to this phenomenon as Slp2-a “tip localization” in the following.
To study the role of the C2 domains in Slp2-a tip localization, we performed live-cell confocal microscopy with Slp2a-ΔC2AB-GFP. In contrast to wild-type Slp2-a, we did not observe any evidence of Slp2a-ΔC2AB-GFP tip localization (Fig. 3B, Video 4). We quantified tip localization of the wild-type and ΔC2AB constructs by assessing the degree of overlap between their respective fluorescent signals and that of VWF-RFP in resting cells, and again shortly after stimulation but before many WPB had fused. The degree of co-registration of Slp2-a and VWF positive pixels is significantly reduced after stimulation for the wild type, indicative of tip localization (Fig. 3A). In contrast, co-registration remains virtually the same for the ΔC2AB construct before and after histamine stimulation (Fig. 3B).
We next assessed whether Slp2-a tip localization is secondary to a potential tip localization of its binding partner Rab27a. Therefore, we co-transfected HUVEC with Rab27a-strby and Slp2a-GFP and again performed live-cell microscopy. After histamine stimulation, Slp2a-GFP clearly assumed tip-localization, whereas the Rab27a-strby signal remained in the typical WPB shape until fusion (Fig. 3C). Collectively, these data suggest that Slp2-a tip localization on WPB is triggered by histamine stimulation, independent of Rab27a, and rather mediated by the Slp2-a C2AB domains. A careful observation of the individual WPB fusion events revealed that the WPB tip positive for Slp2a-GFP was the part of the organelle that fused with the plasma membrane (Fig. 4, Video 5). We, therefore, hypothesized that Slp2-a, via the lipid-binding capability of its C2 domains, establishes contact with the plasma membrane after Ca2+-elevation, and thereby confers special fusion competence to the WPB tip it accumulates on.
Recently, Sharda et al. [40] reported that the exocyst complex, in addition to supporting the trafficking of endolysosomal components to maturing WPB which is mediated by interactions with the biogenesis of lysosome-related organelle-2 (BLOC-2), can act at the plasma membrane as a clamp impeding WPB exocytosis. As this exocyst action could benefit from a tip-end orientation of WPB [40], we also analyzed a potential involvement of exocyst in Slp2-a tip-end enrichment. However, exocyst inhibition by the EXO70-binding Endosidin2 had no significant effect on the histamine-induced enrichment of Slp2-a at WPB tips (Fig. S2).
Slp2-a is a positive regulator of the secretion of highly multimeric VWF
Francis et al. could show recently that Slp2-a is an upstream regulator of WPB exocytosis in the course of angiogenic lumen formation and that Slp2-a knockdown reduces stimulus-evoked VWF secretion [33]. Extending these findings, our analysis of VWF secretion after Slp2-a depletion (Fig. S3) revealed a reduction of both, the histamine-triggered release of VWF to the cell culture medium and the amount of exocytosed VWF appearing on the cell surface, which was detected using an anti-VWF antibody capture assay [11, 41] (Fig. 5A). Interestingly, though being statistically significant this reduction was rather modest as also observed before by analyzing the amount of intracellular VWF after stimulation of Slp2-a depleted cells [33]. Several other Rab27a effectors are known to be recruited to WPB and to regulate WPB exocytosis, in particular MyRIP and Slp4-a [10, 17]. Therefore, we also analyzed whether their WPB association is affected by Slp2-a knockdown which could result in indirect effects on WPB exocytosis. However, the localization of MyRIP and Slp4-a to WPB is not affected in a significant manner in Slp2-a depleted cells (Fig. S4). As the above secretion assays do not differentiate between low- and high-molecular-weight VWF multimers, we also performed type III collagen-binding assays which preferentially detect high-molecular-weight multimers among the VWF released into the cell culture supernatant [42,43,44]. Figure 5B shows that the type III collagen-binding capability of VWF secreted following histamine stimulation was significantly reduced in Slp2-a knockdown conditions as compared to control siRNA-treated cells. A similar reduction in VWF-collagen binding was observed upon Rab27a knockdown, which had been shown before to result in the release of less multimeric VWF [17]. This suggests that Slp2-a promotes exocytosis of fully matured WPB that contain highly multimeric VWF and are characterized by the rod-like morphology.
We next attempted to interfere with Slp2-a function by overexpressing the SH domain as this construct is recruited to WPB (Fig. 2) and likely acts in a competitive, dominant-negative manner. Figure 5C shows that expression of Slp2a-SHDonly-GFP leads to a modest but significant reduction in the histamine-evoked release of VWF, the extent of this reduction being similar to that observed upon Slp2-a knockdown. In contrast, overexpression of full-length Slp2a-GFP has no significant effect.
Together these data suggest that by tethering mature WPB via their tips to the PM, Slp2-a likely affects only this WPB population, and thus, Slp2-a depletion or SHD overexpression causes an only a modest effect on the total evoked VWF release. Interestingly, in gastric-surface mucous cells, Slp2-a has also been linked to the PM targeting of mucus-containing secretory granules but appears to be largely dispensable for evoked mucus secretion [35].
A potential role of Slp2-a in linking the tips of WPB to the PM should reflect itself in the alteration of structures that depend on such fusion topology. Rings or coats of polymerized actin have been shown to form at the base of WPB following fusion with the PM and these actin rings in conjunction with myosin motor activity have been reported to support the expulsion of highly multimeric VWF from fused WPB by driving a movement of the fused granule toward the PM [31]. Such activity would benefit from a tip-end fusion topology, and therefore, we analyzed the formation of actin rings in live HUVEC by employing Lifeact-GFP as marker. Depletion of Slp2-a significantly reduced the number of actin rings at WPB–PM fusion sites supporting the view that Slp2-a fosters a tip-end fusion topology as prerequisite for the assembly of actin rings at the distal end of fused WPB, which in turn support the expulsion of highly multimeric VWF (Fig. 6).
PI(4,5)P2-rich PM domains likely function as Slp2-a interaction sites
Slp2-a is known to interact with the negatively charged lipids PI(4,5)P2 and PS [34]. Interestingly, PI(4,5)P2 has recently been shown to accumulate at WPB–PM fusion sites and specific depletion of PI(4,5)P2 in the plasma membrane resulted in compromised secretagogue-stimulated WPB exocytosis and VWF secretion [27]. In contrast, PS shows no specific accumulation at WPB–PM fusion sites but appears to be slightly enriched in the membrane of resting WPB with this enrichment being lost upon histamine stimulation [27]. Because of these dynamic changes in the distribution of the Slp2-a binding lipids PI(4,5)P2 and PS in the course of secretagogue-evoked WPB exocytosis, we next investigated the influence of Slp2-a lipid binding on its tip localization in a more specific manner exploiting mutations in the C2A domain of Slp2-a that interfere with lipid binding [34]. Slp2a-KQ-C2A, in which 5 lysines within the C2A domain that are essential for binding of negatively charged lipids are mutated to glutamines, completely lacks binding to either PI(4,5)P2 or PS. In Slp2a-DN-C2A, in which the aspartates critical for Ca2+ binding are mutated to asparagines, the binding of PI(4,5)P2 is unchanged, while the binding of PS is no longer dependent on the Ca2+ concentration [34].
We expressed the respective DN and KQ mutants of Slp2-a as GFP fusions in HUVEC and analyzed their dynamic distribution by live-cell confocal microscopy. As seen for Slp2a-wt-GFP, both mutants localized to VWF-RFP positive WPB in resting HUVEC with cells expressing Slp2a-DN-GFP often displaying a clustering of WPB in the cell periphery (Fig. 7). Histamine treatment of HUVEC expressing the DN and KQ mutants triggered abundant WPB–PM fusions, suggesting that neither mutant exhibited a strong dominant-negative phenotype on evoked WPB exocytosis at the expression level achieved here. We did not attempt to systematically quantify WPB–PM fusions within our confocal dataset to avoid ambiguity due to out-of-focus events. Moreover, the tight clustering of WPB in Slp2a-DN-GFP overexpressing cells precluded the identification of single fusion events in many cases. However, we were able to study tip localization—or the lack thereof—of the Slp2-a mutants, precisely because WPB fusions still took place. Compared to Slp2a-wt-GFP, the propensity for tip localization in Slp2a-DN-GFP seems normal (Fig. 7, Video 6). In stark contrast, we observed no evidence of tip localization of Slp2a-KQ-GFP after histamine stimulation (Fig. 7, Video 7). Together, these data indicate that tip localization of Slp2-a requires lipid binding via the C2A domain of Slp2-a, most likely involving an interaction of Slp2-a with PM PI(4,5)P2 that is enriched at WPB–PM fusion sites.
To further substantiate a potential role of PM PI(4,5)P2 in mediating Slp2-a tip localization, we analyzed the Slp2-a behavior in cells depleted of phospatidyl 4-phopshate 5-kinase γ (PI4P5Kγ), the major enzyme generating PI(4,5)P2 in HUVEC. We had shown before that this depletion and a reduction in PM PI(4,5)P2 interfere with histamine-evoked WPB exocytosis [27]. Interestingly, PI4P5Kγ knockdown also results in a significant reduction in the extent of Slp2-a tip localization after histamine stimulation (Fig. S5). This supports the hypothesis that PM PI(4,5)P2 participates in promoting Slp2-a tip localization prior to WPB–PM fusion.
Discussion
In this work, we investigated the possibility that an elongated, rod-shaped organelle, here the WPB of endothelial cells, can initiate fusion with the PM preferentially at one of its tips. We present evidence that the frequency of tip fusions outweighs that of strictly lateral fusions, at least for histamine-stimulated conditions. In search for factors potentially mediating this tip-end (or polar) fusion, we identify Slp2-a as a WPB-associated protein that becomes enriched at the organelle tip which will undergo fusion. Slp2-a, the depletion of which decreases the extent of histamine-induced, Ca2+-dependent secretion of highly multimeric VWF, is a PI(4,5)P2 and PS-binding protein. Its phospholipid-binding sites are located in the Ca2+ regulated C2A domain and we show that this domain, and in particular its PI(4,5)P2/PS-binding lysine residues, is required for Slp2-a tip localization following histamine stimulation. As PI(4,5)P2 but not PS accumulates at WPB–PM fusion sites and its depletion interferes with Ca2+-regulated WPB exocytosis [27], we interpret these data to indicate that Slp2-a is instrumental in establishing contact between PM PI(4,5)P2 and the tips of fusing WPB. Thus, Slp2-a is required for efficient tip-end fusion and beneficial for the release of highly multimeric VWF, but not for WPB–PM fusion per se explaining the relatively mild inhibitory effect of Slp2-a knockdown on total VWF secretion.
Why do WPB preferentially initiate fusion at one of their tips? On one hand, high membrane curvature is beneficial for efficient fusion [45]. The nearly hemispherical tips of WPB represent the most highly curved membrane regions of the organelle, and a local accumulation of Slp2-a on the pre-fusion WPB tip would serve to further functionalize this membrane region. On the other hand and apart from biophysical considerations, tip fusion conceivably has advantages for cargo release. VWF expulsion from WPB is regulated by the de-acidification of the organelle lumen [46], and VWF tubules are “spring-loaded” for cargo release upon de-acidification of the organelle lumen following WPB–PM fusion [47]. The resulting “unspooling” of VWF tubules that lead to VWF string formation in the blood vessel is more naturally accomplished along the length of VWF tubules present in a tip-fused configuration. An alternative or additional mechanism for VWF release provided by a contractile actin ring around WPB expelling VWF by actomyosin-driven forces is also reconciled more easily with tip fusions rather than lateral cargo release as the actin ring has been shown to form at the base of a (tip) fused WPB and appears to push the fused elongated granule toward the plasma membrane [31]. In line with these considerations and the requirement of Slp2-a for tip-end fusion, Slp2-a knockdown reduces the number of actin rings at WPB–PM fusion sites and the amount of highly multimeric VWF released following histamine stimulation. Apart from supporting efficient release of large multimeric VWF, tip fusion would also benefit kiss-and-run and cavicapture type fusion events of the large asymmetric WPB. Furthermore, it also is possible that tip fusion regulates the release of (unknown) factor(s) that are concentrated at one end of mature WPB.
How is the Slp2-a accumulation at the WPB tip which will undergo fusion achieved? While Slp2-a recruitment to WPB depends on Rab27a, stimulation-dependent tip localization is only undergone by Slp2-a itself, and not by Rab27a. We think that it is likely that Ca2+-dependent changes in Slp2-a/lipid interactions at the PM and also the organelle membrane are the driving factor in stimulus-induced Slp2-a tip localization. PS binding by Slp2-a is efficiently inhibited by Ca2+ concentrations within the physiological range for exocytosis events, while PI(4,5)P2 binding is largely unaffected by Ca2+ [34]. As PS is slightly enriched in the WPB membrane of resting but not histamine-stimulated HUVEC [27], we speculate that Slp2-a binds via its C2A domain to PS on the WPB membrane in resting HUVEC at low intracellular Ca2+ concentrations. After histamine stimulation, this PS binding would be weakened, which might allow the C2A domain of WPB-localized Slp2-a to bind PM-resident PI(4,5)P2 instead (Fig. 7B). As a consequence, Slp2-a would be enriched at that part of the WPB which allows for interactions with PM PI(4,5)P2. Additional PI(4,5)P2 and/or phosphatidic acid (PA), another anionic phospholipid known to accumulate at WPB–PM fusion sites [27] might be laterally recruited toward the future site of exocytosis, and the interaction between organelle and plasma membrane would be strengthened. By switching from PS to PI(4,5)P2-binding in a Ca2+-dependent manner, Slp2-a would thus ensure sufficient proximity between WPB tips and the PM to favor subsequent fusion in this topology. In this model, the WPB tip that develops the Slp2-a accumulation would simply be the one in closest proximity to the plasma membrane, and in consequence, closest to a source of PI(4,5)P2. We have currently no indication that the two tips of any single WPB are inherently different from each other before Slp2-a accumulation, apart from their relative positions within the cell. This model, however, does not fully explain the behavior of the Slp2a-DN mutant which accumulates at WPB tips after histamine stimulation albeit apparently not being able to respond to rising Ca2+ concentration by a weakening of the PS binding. We speculate that the PI(4,5)P2 binding of this mutant is so dominant that it can still promote tip localization despite an unaltered PS interaction. As an alternative to PM lipids (PI(4,5)P2, PA) promoting tip localization of Slp2-a, the higher curvature at WPB tips or a yet to be identified factor recruited specifically to WPB tips could participate in mediating Slp2-a enrichment. However, recruitment of such factor would have to be stimulus-dependent as Slp2-a localizes over the entire WPB in resting, unstimulated HUVEC.
With MyRIP, Slp4-a, Munc13-4, and Slp2-a all affecting VWF secretion from endothelial cells, the involvement of Rab27a effectors in WPB exocytosis has now reached a certain level of complexity. However, not all of these act as Rab27a effectors exclusively: Slp4-a is initially recruited to WPB by Rab3 [10], and Rab27a is dispensable for Munc13-4 recruitment to WPB [14, 39]. Nevertheless, the question arises why so many Rab27a effectors are involved in this process. A potential explanation may lie in the fact that while endothelial cells are apico-basally polarized in vivo, most experiments addressing the molecular mechanisms of WPB exocytosis so far have been performed in non-polarized cell culture systems. One exception is a study that revisited the long-standing issue of how strongly VWF secretion is polarized, and found the regulated release of VWF to occur predominantly apically, i.e., toward the blood vessel lumen [48]. Intriguingly, Slp2-a was described earlier to not only act in establishing apico-basal polarity within renal epithelial cells [38, 49], but also to be involved in targeting fusiform vesicles, another class of large, curved secretory vesicles, toward the apical domain of urothelial umbrella cells [50]. Importantly, in endothelial cells, a recent study could show that Slp2-a supports the WPB-mediated apical secretion of angiopoietin-2 [33]. In MDCK II cells, Slp2-a expression is strongly upregulated in 3D differentiated cells compared to non-polarized growth conditions. In this respect, it is interesting to note that we also observed an upregulation of Slp2-a mRNA expression when HUVEC reach confluency in culture, i.e., when a first apico-basal polarity is established (Fig. S6). A specific role of Slp2-a in apical VWF secretion is also supported by the involvement of PI(4,5)P2, which is enriched in the apical PM of epithelial cells [51]. Moreover, in Jurkat cells, an interdependence between Rab27a/Slp2-a protein abundance and PI(4,5)P2 content of the plasma membrane has been found in the context of secretion of HIV particles [52]. Thus, Slp2-a likely functions in conjunction with PI(4,5)P2-rich PM domains in supporting a unique tip-end tethering and eventually fusion of WPB, thereby permitting a regulation of selective WPB cargo release.
Materials and methods
Cell culture and transfection
HUVEC were obtained from Promocell and cultured in a mixed endothelial growth medium, a 1:1 mixture of ECGM-2 (C-22111, Promocell) and M199 (F0615, Biochrom) + 10% fetal calf serum (Sigma) + 100 i.u. heparin (Ratiopharm), supplemented with 0.015 µg/ml amphotericin B (Biochrom) and 30 µg/ml gentamycin (CytoGen), at 37 °C and 5% CO2 for up to five passages. HUVEC were transfected with plasmids or siRNAs using the Amaxa Nucleofection Technology (HUVEC Nucleofector Kit-OLD, Lonza) as described previously [13]. Transfections with plasmid DNA used 1–10 µg DNA per 20 cm2 of nearly confluent HUVEC. VWF-EGFP [53], VWF-RFP [54], and Lifeact-GFP [55] were described before and kindly provided by Tom Carter (St. George University, London) and Roland Wedlich-Söldner (University of Münster), respectively. Rab27a-EGFP was generated by amplification of the Rab27a cDNA from a HUVEC cDNA library using specific primers that included EcoRI and BamHI restriction sites at the 5′ and 3′ end, respectively, and cloning of the PCR product into the pEGFP-C1 vector (Clontech).
-
Rab27F1: CCGGAATTCAATCTCTGATGGAGATTATG
-
Rab27R: CGCGGATCCTCAACAGCCACATGCCCCTT
Rab27a-strby was then generated by exchanging the fluorophore of Rab27a-EGFP, using pmStrawberry (Clontech) as the fluorophore source and specific primers with the restriction sites AgeI and BamHI at the 5′ and 3′ end, respectively. Slp2a-wt-GFP, Slp2a-ΔC2AB-GFP, Slp2a-ΔSHD-GFP, Slp2a-SHDonly-GFP, Slp2a-E11A/R32A-GFP, and Slp2a-V18A-GFP have been described [38]. Slp2a-DN-GFP and Slp2a-KQ-GFP were generated by site-directed mutagenesis to match the single amino acid changes described in [34] using the Q5 site-directed mutagenesis kit (New England Biolabs) according to the manufacturer’s instructions in two rounds of mutagenesis each using the following primers:
-
KQ1: CAAAGGCAAAATGGGCCAGCAGCAAACACTCGTAGTGAAGAAAAC
-
KQ2: GCAGCAAACACTCGTAGTGCAGCAAACCTTGAATCCTGTG
-
DN1: CTTAGCAGCAGCGAATGTAAAAAAACAGCGTTCAAACCCATATGTAAAGG
-
DN2: GAACCTGTCCATTTGGCATCGGAATACATTTAAGCG.
Transfections with siRNAs used 400 pmol targeting or control siRNA per 20 cm2 dish of nearly confluent HUVEC. Rab27a was depleted using the siRNA 5′GGAGAGGUUUCGUAGCUUA-dTdT (Sigma), and Slp2 with siSlp2 5′CGUUCAGACCCAUAUGUAA-dTdT (Microsynth). For control conditions, AllStars Neg. Control siRNA (siCtrl) (102,781, Qiagen) was used. After incubation for 48 h, siRNA transfection was repeated with or without any additionally required plasmid DNA. Cells were used for experiments 48 h after the second round of transfection.
Knockdown of PI4P5Kγ was performed as described by Nguyen et al. [27]. Inhibition of Exo70 with Endosidin2 was performed by treating HUVEC for 2 h at 37 °C and a final concentration of 10 µM [40].
Microscopy
HUVEC transfected with the appropriate constructs were seeded in 8-well glass bottom µ-slides (ibidi) pretreated with collagen type I from rat tail (Millipore). During acquisition, cells were maintained in a mixed endothelial growth medium containing 20 mM HEPES at 37 °C in the incubation chamber of the respective microscope. Histamine stimulation during acquisition was performed manually by adding 100 × concentrated histamine stock solution to final concentrations ranging from 20 to 500 µM as indicated in the respective figure legends.
Confocal microscopy was performed on an LSM780 confocal system (Zeiss) using a 63 × , NA 1.4 oil immersion objective (Plan-Apochromat, Zeiss) or on an LSM800 confocal system (Zeiss). TIRF microscopy with simultaneous epifluorescence illumination was performed on an Olympus IX71 TIRF Microscope customized to include a heated incubation chamber, an objective-type TIRFM setup from TILL Photonics, a monochromator for epifluorescence excitation, and a controller allowing hardware-controlled fast switching between total internal reflection fluorescence and epifluorescence (TILL Photonics). Images were acquired using a TILL Image QE charge-coupled device camera (TILL Photonics) and MetaMorph Software (Molecular Devices). The total internal reflection angle was manually adjusted for every experiment. TIRF movies were recorded with 2–5 frames per second. Image analysis for fusion mode (tip vs. lateral fusion) was done in Fiji [56, 57].
Preparation of microscopic images for figures was performed in Fiji using linear brightness/contrast adjustments only. For assessment of Slp2a-GFP tip localization on WPB, two time-points were chosen in the recording of each histamine stimulation experiment analyzed: (1) the first, pre-stimulation image, and (2) a time-point post-stimulation at which some, but not all WPB fusions had occurred. To compare the occupancy of Slp2a-GFP on VWF-RFP-positive objects before and after stimulation, each image was processed as follows: First, each bicolor image was split into its constituent channels; then, object segmentation was performed on the VWF-RFP channel by manually adjusting and applying a threshold, creating a binary mask (Image—> adjust—> threshold—> manually select—> apply; edit—> selection—> create mask). The mask was then loaded into the ROI manager (edit—> selection—> create selection; analyze—> tools—> ROI manager—> add). To segment the WPB in the Slp2a-GFP channel, the VWF-RFP mask was then applied to the Slp2a-GFP channel (select green channel image—> select VWF-RFP ROI in ROI manager- > edit—> clear outside; image—> adjust threshold—> apply; edit—> selection—> create mask), and subsequently loaded to the ROI manager as well. With these tools and the command “measure” in the ROI manager, the area occupied by the VWF signal in the VWF-RFP channel, and the area covered by the Slp2a-GFP signal within the VWF-RFP mask were measured each. The area representing Slp2a-GFP occupancy on WPB was then expressed as a percentage of the VWF-RFP mask representing the entire WPB to compare pre-stimulation and post-stimulation time-points. The statistical significance of results was assessed using the unpaired t test in GraphPad Prism.
To microscopically analyze the formation of actin rings at WPB–PM fusion sites, one cell per well was recorded. The cell was divided into 8 z-stacks that were recorded one after another. After completion of the first complete z-stack, histamine was added to a final concentration of 500 µM and microscopy was performed for approximately 5 min per cell. Statistical significance of results was assessed using the unpaired Mann–Whitney test in GraphPad Prism.
Immunofluorescence staining
HUVEC were seeded on collagen-coated 12 mm glass coverslips and cultivated at 37 °C, 5% CO2. Cells were fixed in 4% PFA in 1 × PBS for 10 min at RT and subsequently permeabilized using 0.1% Triton X-100 for 2 min. After blocking (3% BSA in 1 × PBS) for 30 min, primary antibodies were applied at the dilutions indicated. Cells were washed and treated with secondary antibodies and DAPI, if applicable. After the final washing, HUVEC were mounted on glass slides using Mowiol. Samples were analyzed using a confocal laser scanning microscope LSM800 (Zeiss). Primary antibodies used: rabbit-anti-Slp4-a, Atlas Antibodies; ms-a-VWF, DAKO; goat-anti-MyRIP, Abcam.
Western blotting and antibodies
HUVEC lysate was prepared by harvesting cells from a 20 cm2 dish with trypsin/EDTA, washing the cell pellet in PBS once, and lysing the cells by sonication for 1 min in 40 μl lysis buffer (20 mM HEPES, 150 mM NaCl, 0.5% Triton X-100, 1.5 mM PMSF and complete EDTA-free protease inhibitor cocktail (11,873,580,001, Roche) added according to the manufacturer’s instructions). After incubation on ice for 15 min, cellular debris was pelleted (10 min, 1250 × g, 4 °C) and the cleared lysate was subjected to SDS-PAGE and Western blotting according to the standard protocols. For characterization of Rab27 effectors expressed in HUVEC, 40 µg of the lysate was loaded per lane and compared to T7-tagged proteins expressed in COS7 cells. SDS-PAGE was performed in 7.5% acrylamide gels, and Western blotting was carried out as described with primary antibodies generated previously [58, 59]. For characterization of Slp2a-GFP knockdown efficiency, the primary antibodies used were mouse anti-β actin mAB, clone AC-15 (Sigma-Aldrich) (loading control), and rabbit anti-GFP pAB (Invitrogen). The secondary antibodies used were goat anti-rabbit IRDye 680 (LICOR) and goat anti-mouse IRDye 800 (LICOR), imaged with an Odyssey Infrared Imaging System (Application Software version 3.0, LICOR).
Secretion assay
HUVEC grown to full confluency were used for all secretion assays. Stimulation was performed with 100 µM histamine (Sigma-Aldrich). SiRNA-treated HUVEC were used approx. 48 h after the second round of transfection. The amount of secreted VWF was quantified by enzyme-linked immunosorbent assay (ELISA) as previously described [18], analyzing three triplicate samples per condition (supernatant of unstimulated cells, of stimulated cells, and total lysates). The amount of VWF secreted into the cell culture supernatant was then expressed as percentage of total VWF content (amount of VWF of all three samples combined, that is, supernatant of nonstimulated plus supernatant of stimulated cells plus remaining total lysate). This analysis allowed for controlling for differences in total VWF content between each replicate and each condition. The collagen-binding capability of secreted VWF was determined using a well-established collagen-ELISA, in addition to the described VWF-ELISA [42, 43]. In brief, ELISA plates were coated with human type III collagen (Southern Biotech) and then processed similar to the VWF-antigen-ELISA. Collagen-binding ratio was calculated by evaluating the ratio between collagen-binding and VWF antigen levels. Secretion assays in which control stimulation reached < 18% were excluded from the analysis. Statistical significance was assessed with paired t tests in SPSS or in GraphPad Prism.
Flow cytometry-based capture assay
HUVEC grown to full confluency were used for all capture assays. Stimulation was performed with 100 µM histamine (Sigma-Aldrich). SiRNA-treated HUVEC were used approx. 48 h after the second round of transfection. GFP transfected HUVEC were used approx. 24 h after transfection. HUVEC were treated with rabbit-anti-VWF antibodies (DAKO) for 20 min in basal medium (2% (w/v) BSA in M199) to saturate non-specific binding sites. Cells were then washed and treated with rabbit-anti-VWF DyLight™ 650 antibodies with or without stimulant (histamine), for 20 min in a basal medium. Subsequently, HUVEC were washed and deattached from the dish using Accutase (PAA). After centrifugation (4 min, 4 °C, 200*g), cells were washed and then fixed and permeabilized by applying Fixation/Permeabilization solution (BD Cytofix/Cytoperm™) for 20 min. Cells were then blocked (BD Perm/Wash™ Buffer) for 15 min. For staining of total VWF, HUVEC were treated with rabbit-anti-VWF DyLight™ 405 antibodies for 1 h, washed three times with 5% BSA (w/v) in 1xPBS, and subsequently analyzed. Per condition 10.000 cells (in case of GFP constructs 10.000 GFP expressing cells) were counted and analyzed for their surface VWF (DyLight™ 650) and total VWF (DyLight™ 405) signal intensities on a Guava® easyCyte™ Flow Cytometer. The statistical significance of results was assessed using the t test or ANOVA with Dunnett's post hoc test in GraphPad Prism.
Real-time PCR
RNA from HUVEC was isolated using RNEasy Mini Kit (Qiagen). For cDNA Synthesis 1 µg of RNA was transcribed using High-Capacity cDNA Reverse-Transcription Kit (Thermo Fisher Scientific). Real-time PCR was performed with Brilliant III Ultra-Fast SYBR® Green qPCR Mastermix (Agilent) on a Roche LightCycler 480 according to the manufacturer’s instructions. Analysis was performed using the \({2}^{-\Delta \Delta {\mathrm{C}}_{\mathrm{T}}}\)-Method [60]. The following primers were used:
-
VWF-fw: CCT TGA ATC CCA GTG ACC CTG A
-
VWF-rev: GGT TCC GAG ATG TCC ACA T
-
Slp2: Hs_SYTL2_1_SG QuantiTect Primer Assay QIAGEN (Cat. No. QT01021629)
-
ACTB: Hs_ACTB_1_SG QuantiTect Primer Assay QIAGEN (Cat. No. QT00095431)
-
B2M: Hs_B2M_1_SG QuantiTect Primer Assay QIAGEN (Cat. No. QT00088935)
Housekeeping genes: β-Actin (ACTB) and β2-Mikroglobulin (B2M). Statistical significance of results was assessed using the unpaired t test or Mann–Whitney test in GraphPad Prism.
Statistics
All statistical analyses were performed using GraphPad Prism or IBM SPSS Statistics. Asterisks mark statistically significant results: ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05. Normal distribution was assessed by the Shapiro–Wilk test, p < 0.05. Normally distributed data were analyzed employing Student’s t test or one-way ANOVA with Dunnett’s post hoc test (> 2 conditions). Non-parametric data were analyzed using Mann–Whitney test.
Availability of data and materials
The datasets generated during and/or analyzed during the current study are available from the corresponding author (gerke@uni-muenster.de) on reasonable request.
Code availability
Not applicable.
References
Lenting PJ, Christophe OD, Denis CV (2015) von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends. Blood 125:2019–2028. https://doi.org/10.1182/blood-2014-06-528406
McCormack JJ, Lopes da Silva M, Ferraro F et al (2017) Weibel−Palade bodies at a glance. J Cell Sci 130:3611–3617. https://doi.org/10.1242/jcs.208033
Schillemans M, Karampini E, Kat M, Bierings R (2019) Exocytosis of Weibel-Palade bodies: how to unpack a vascular emergency kit. J Thromb Haemost 17:6–18. https://doi.org/10.1111/jth.14322
Naß J, Terglane J, Gerke V (2021) Weibel Palade bodies: unique secretory organelles of endothelial cells that control blood vessel homeostasis. Front Cell Dev Biol 9:3621. https://doi.org/10.3389/fcell.2021.813995
Bonfanti R, Furie BC, Furie B, Wagner DD (1989) PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 73:1109–1112
Vischer UM, Wagner DD (1993) CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 82:1184–1191
Doyle EL, Ridger V, Ferraro F et al (2011) CD63 is an essential cofactor to leukocyte recruitment by endothelial P-selectin. Blood 118:4265–4273. https://doi.org/10.1182/blood-2010-11-321489
Wagner DD, Frenette PS (2008) The vessel wall and its interactions. Blood 111:5271–5281. https://doi.org/10.1182/blood-2008-01-078204
Leebeek FWG, Eikenboom JCJ (2016) Von Willebrand’s disease. N Engl J Med 375:2067–2080. https://doi.org/10.1056/NEJMra1601561
Bierings R, Hellen N, Kiskin N et al (2012) The interplay between the Rab27A effectors Slp4-a and MyRIP controls hormone-evoked Weibel-Palade body exocytosis. Blood 120:2757–2767. https://doi.org/10.1182/blood-2012-05-429936
Biesemann A, Gorontzi A, Barr F, Gerke V (2017) Rab35 protein regulates evoked exocytosis of endothelial Weibel-Palade bodies. J Biol Chem 292:11631–11640. https://doi.org/10.1074/jbc.M116.773333
Hannah MJ, Hume AN, Arribas M et al (2003) Weibel-Palade bodies recruit Rab27 by a content-driven, maturation-dependent mechanism that is independent of cell type. J Cell Sci 116:3939–3948. https://doi.org/10.1242/jcs.00711
Knop M, Aareskjold E, Bode G, Gerke V (2004) Rab3D and annexin A2 play a role in regulated secretion of vWF, but not tPA, from endothelial cells. EMBO J 23:2982–2992. https://doi.org/10.1038/sj.emboj.7600319
Zografou S, Basagiannis D, Papafotika A et al (2012) A complete Rab screening reveals novel insights in Weibel-Palade body exocytosis. J Cell Sci 125:4780–4790. https://doi.org/10.1242/jcs.104174
Kat M, Bürgisser PE, Janssen H et al (2021) GDP/GTP exchange factor MADD drives activation and recruitment of secretory Rab GTPases to Weibel-Palade bodies. Blood Adv. https://doi.org/10.1182/bloodadvances.2021004827
Conte IL, Hellen N, Bierings R et al (2016) Interaction between MyRIP and the actin cytoskeleton regulates Weibel-Palade body trafficking and exocytosis. J Cell Sci 129:592–603. https://doi.org/10.1242/jcs.178285
Nightingale TD, Pattni K, Hume AN et al (2009) Rab27a and MyRIP regulate the amount and multimeric state of VWF released from endothelial cells. Blood 113:5010–5018. https://doi.org/10.1182/blood-2008-09-181206
Rojo Pulido I, Nightingale TD, Darchen F et al (2011) Myosin Va acts in concert with Rab27a and MyRIP to regulate acute von-Willebrand factor release from endothelial cells. Traffic Cph Den 12:1371–1382. https://doi.org/10.1111/j.1600-0854.2011.01248.x
van Breevoort D, Snijders AP, Hellen N et al (2014) STXBP1 promotes Weibel-Palade body exocytosis through its interaction with the Rab27A effector Slp4-a. Blood 123:3185–3194. https://doi.org/10.1182/blood-2013-10-535831
Matsushita K, Morrell CN, Cambien B et al (2003) Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 115:139–150
Rojo Pulido I, Jahn R, Gerke V (2011) VAMP3 is associated with endothelial Weibel-Palade bodies and participates in their Ca(2+)-dependent exocytosis. Biochim Biophys Acta 1813:1038–1044. https://doi.org/10.1016/j.bbamcr.2010.11.007
Zhou Y, Yang S-X, Yue Y-N et al (2016) N-ethylmaleimide-sensitive factor siRNA inhibits the release of Weibel-Palade bodies in endothelial cells. Mol Med Rep 14:1061–1066. https://doi.org/10.3892/mmr.2016.5372
Fu J, Naren AP, Gao X et al (2005) Protease-activated receptor-1 activation of endothelial cells induces protein kinase Calpha-dependent phosphorylation of syntaxin 4 and Munc18c: role in signaling p-selectin expression. J Biol Chem 280:3178–3184. https://doi.org/10.1074/jbc.M410044200
Zhu QM, Zhu Q, Yamakuchi M, Lowenstein CJ (2015) SNAP23 regulates endothelial exocytosis of von Willebrand factor. PLoS ONE 10:e0118737. https://doi.org/10.1371/journal.pone.0118737
Schillemans M, Karampini E, van den Eshof BL et al (2018) Weibel-Palade body localized syntaxin-3 modulates Von Willebrand factor secretion from endothelial cells. Arterioscler Thromb Vasc Biol 38:1549–1561. https://doi.org/10.1161/ATVBAHA.117.310701
Disse J, Vitale N, Bader M-F, Gerke V (2009) Phospholipase D1 is specifically required for regulated secretion of von Willebrand factor from endothelial cells. Blood 113:973–980. https://doi.org/10.1182/blood-2008-06-165282
Nguyen TTN, Koerdt SN, Gerke V (2020) Plasma membrane phosphatidylinositol (4,5)-bisphosphate promotes Weibel-Palade body exocytosis. Life Sci Alliance 3:e202000788. https://doi.org/10.26508/lsa.202000788
Erent M, Meli A, Moisoi N et al (2007) Rate, extent and concentration dependence of histamine-evoked Weibel-Palade body exocytosis determined from individual fusion events in human endothelial cells. J Physiol 583:195–212. https://doi.org/10.1113/jphysiol.2007.132993
Mietkowska M, Schuberth C, Wedlich-Söldner R, Gerke V (2019) Actin dynamics during Ca2+-dependent exocytosis of endothelial Weibel-Palade bodies. Biochim Biophys Acta BBA - Mol Cell Res 1866:1218–1229. https://doi.org/10.1016/j.bbamcr.2018.11.010
Nightingale TD, McCormack JJ, Grimes W et al (2018) Tuning the endothelial response: differential release of exocytic cargos from Weibel-Palade bodies. J Thromb Haemost 16:1873–1886. https://doi.org/10.1111/jth.14218
Nightingale TD, White IJ, Doyle EL et al (2011) Actomyosin II contractility expels von Willebrand factor from Weibel-Palade bodies during exocytosis. J Cell Biol 194:613–629. https://doi.org/10.1083/jcb.201011119
Berriman JA, Li S, Hewlett LJ et al (2009) Structural organization of Weibel-Palade bodies revealed by cryo-EM of vitrified endothelial cells. Proc Natl Acad Sci 106:17407–17412. https://doi.org/10.1073/pnas.0902977106
Francis CR, Claflin S, Kushner EJ (2021) Synaptotagmin-like protein 2a regulates angiogenic lumen formation via Weibel-Palade body apical secretion of angiopoietin-2. Arterioscler Thromb Vasc Biol. https://doi.org/10.1161/ATVBAHA.121.316113
Yu M, Kasai K, Nagashima K et al (2007) Exophilin4/Slp2-a targets glucagon granules to the plasma membrane through unique ca2+-inhibitory phospholipid-binding activity of the c2a domain. Mol Biol Cell 18:688–696. https://doi.org/10.1091/mbc.E06-10-0914
Saegusa C, Tanaka T, Tani S et al (2006) Decreased basal mucus secretion by Slp2-a-deficient gastric surface mucous cells. Genes Cells 11:623–631. https://doi.org/10.1111/j.1365-2443.2006.00964.x
Holt O, Kanno E, Bossi G et al (2008) Slp1 and Slp2-a localize to the plasma membrane of CTL and contribute to secretion from the immunological synapse. Traffic 9:446–457. https://doi.org/10.1111/j.1600-0854.2008.00714.x
Ménasché G, Ménager MM, Lefebvre JM et al (2008) A newly identified isoform of Slp2a associates with Rab27a in cytotoxic T cells and participates to cytotoxic granule secretion. Blood 112:5052–5062. https://doi.org/10.1182/blood-2008-02-141069
Gálvez-Santisteban M, Rodriguez-Fraticelli AE, Bryant DM et al (2012) Synaptotagmin-like proteins control the formation of a single apical membrane domain in epithelial cells. Nat Cell Biol 14:838–849. https://doi.org/10.1038/ncb2541
Chehab T, Criado Santos N, Holthenrich A et al (2017) A novel Munc13-4/S100A10/annexin A2 complex promotes Weibel-Palade body exocytosis in endothelial cells. Mol Biol Cell 28:1688–1700. https://doi.org/10.1091/mbc.E17-02-0128
Sharda AV, Barr AM, Harrison JA et al (2020) VWF maturation and release are controlled by 2 regulators of Weibel-Palade body biogenesis: exocyst and BLOC-2. Blood 136:2824–2837. https://doi.org/10.1182/blood.2020005300
Holthenrich A, Terglane J, Naß J et al (2022) Spire1 and Myosin Vc promote Ca2+-evoked externalization of von Willebrand factor in endothelial cells. Cell Mol Life Sci 79:96. https://doi.org/10.1007/s00018-021-04108-x
Flood VH, Gill JC, Christopherson PA et al (2012) Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease. J Thromb Haemost 10:1425–1432. https://doi.org/10.1111/j.1538-7836.2012.04747.x
Bortot M, Ashworth K, Sharifi A et al (2019) Turbulent flow promotes cleavage of VWF (von Willebrand factor) by ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type-1 motif, member 13). Arterioscler Thromb Vasc Biol 39:1831–1842. https://doi.org/10.1161/ATVBAHA.119.312814
Favaloro EJ (2020) Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies. Res Pract Thromb Haemost 4:952–957. https://doi.org/10.1002/rth2.12392
Hernandez JM, Kreutzberger AJB, Kiessling V et al (2014) Variable cooperativity in SNARE-mediated membrane fusion. Proc Natl Acad Sci USA 111:12037–12042. https://doi.org/10.1073/pnas.1407435111
Stevenson NL, White IJ, McCormack JJ et al (2017) Clathrin-mediated post-fusion membrane retrieval influences the exocytic mode of endothelial Weibel-Palade bodies. J Cell Sci 130:2591–2605. https://doi.org/10.1242/jcs.200840
Michaux G, Abbitt KB, Collinson LM et al (2006) The physiological function of von Willebrand’s factor depends on its tubular storage in endothelial Weibel-Palade bodies. Dev Cell 10:223–232. https://doi.org/10.1016/j.devcel.2005.12.012
Lopes da Silva M, Cutler DF (2016) von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells. Blood 128:277–285. https://doi.org/10.1182/blood-2015-10-677054
Yasuda T, Saegusa C, Kamakura S et al (2012) Rab27 effector Slp2-a transports the apical signaling molecule podocalyxin to the apical surface of MDCK II cells and regulates claudin-2 expression. Mol Biol Cell 23:3229–3239. https://doi.org/10.1091/mbc.E12-02-0104
Wankel B, Ouyang J, Guo X et al (2016) Sequential and compartmentalized action of Rabs, SNAREs, and MAL in the apical delivery of fusiform vesicles in urothelial umbrella cells. Mol Biol Cell 27:1621–1634. https://doi.org/10.1091/mbc.E15-04-0230
Martin-Belmonte F, Gassama A, Datta A et al (2007) PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 128:383–397. https://doi.org/10.1016/j.cell.2006.11.051
Gerber PP, Cabrini M, Jancic C et al (2015) Rab27a controls HIV-1 assembly by regulating plasma membrane levels of phosphatidylinositol 4,5-bisphosphate. J Cell Biol 209:435–452. https://doi.org/10.1083/jcb.201409082
Hannah MJ, Skehel P, Erent M et al (2005) Differential kinetics of cell surface loss of von Willebrand factor and its propolypeptide after secretion from Weibel-Palade bodies in living human endothelial cells. J Biol Chem 280:22827–22830. https://doi.org/10.1074/jbc.M412547200
Babich V, Meli A, Knipe L et al (2008) Selective release of molecules from Weibel-Palade bodies during a lingering kiss. Blood 111:5282–5290. https://doi.org/10.1182/blood-2007-09-113746
Wales P, Schuberth CE, Aufschnaiter R et al (2016) Calcium-mediated actin reset (CaAR) mediates acute cell adaptations. Elife 5:e19850. https://doi.org/10.7554/eLife.19850
Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. https://doi.org/10.1038/nmeth.2019
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675
Fukuda M, Kanno E, Yamamoto A (2004) Rabphilin and Noc2 are recruited to dense-core vesicles through specific interaction with Rab27A in PC12 cells. J Biol Chem 279:13065–13075. https://doi.org/10.1074/jbc.M306812200
Imai A, Yoshie S, Nashida T et al (2004) The small GTPase Rab27B regulates amylase release from rat parotid acinar cells. J Cell Sci 117:1945–1953. https://doi.org/10.1242/jcs.01048
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
Acknowledgements
We thank Sarah Hardebeck for technical assistance and Dr. Nina Criado-Santos for the helpful discussion.
Funding
Open Access funding enabled and organized by Projekt DEAL. This work has been supported by grants from the German Research Council (DFG, GE 514/6–3, and SFB 1348). SNK and AB were members, and JN currently is a member of the joint graduate school Cells-in-Motion (CiM)/IMPRS, Münster, Germany.
Author information
Authors and Affiliations
Contributions
S.N.K., J.N., A.B., and V.G. designed and planned the study. S.N.K., J.N., A.B., T.C., and T.Y. performed and analyzed experiments and designed figures. M.F. and F.M.-B. provided valuable expertise, reagents, and discussion. S.N.K. and V.G. wrote the paper with help from J.N., A.B., and T.C.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file2 (MP4 1303 KB)
Supplementary file3 (MP4 29 KB)
Supplementary file4 (MP4 2173 KB)
Supplementary file5 (MP4 6720 KB)
Supplementary file6 (MP4 229 KB)
Supplementary file7 (MP4 252 KB)
Supplementary file8 (MP4 770 KB)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Naß, J., Koerdt, S.N., Biesemann, A. et al. Tip-end fusion of a rod-shaped secretory organelle. Cell. Mol. Life Sci. 79, 344 (2022). https://doi.org/10.1007/s00018-022-04367-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00018-022-04367-2